Peposertib, a DNAPK inhibitor, enhances the antitumor efficacy of anthracyclines in triple-negative breast cancer models in vitro and in vivo Steffie Revia, Christian Sirrenberg, Antonia Schach,Astrid Zimmermann,Frank T. Zenke,Joachim AlbersCANCER RESEARCH（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
